| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 6.504 | 6.464 | 2.070 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 6.504 | 6.504 | 2.073 | 2 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Expenses - EUR | 5.218 | 5.640 | 4.263 | 4.631 | 6.024 | 2.451 | 332 | 0 | 0 | 0 |
| Gross Profit/Loss - EUR | 1.286 | 864 | -2.190 | -4.630 | -6.024 | -2.451 | -332 | 0 | 0 | 0 |
| Net Profit/Loss - EUR | 1.091 | 670 | -2.252 | -4.630 | -6.024 | -2.451 | -332 | 0 | 0 | 0 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Cris Corimed Consulting S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 46 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 415 | 865 | 283 | 80 | 313 | 222 | -114 | -115 | -114 | -114 |
| Inventories | 0 | 19 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 130 | 169 | 346 | 339 | 0 | 0 | 0 | 0 |
| Cash | 415 | 845 | 153 | -88 | -32 | -117 | -114 | -115 | -114 | -114 |
| Shareholders Funds | -747 | -29 | -2.280 | -6.868 | -12.759 | -14.968 | -14.968 | -15.014 | -14.969 | -14.885 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 1.208 | 893 | 2.563 | 6.949 | 13.072 | 15.190 | 14.853 | 14.899 | 14.854 | 14.771 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7022 - 7022" | |||||||||
| CAEN Financial Year |
7022
|
|||||||||
Comments - Cris Corimed Consulting S.r.l.